The potential of methylxanthine-based therapies in pediatric respiratory tract diseases.

Authors :: Oñatibia-Astibia A
Martínez-Pinilla E
Franco R
Source :: Respiratory medicine [Respir Med] 2016 Mar; Vol. 112, pp. 1-9. Date of Electronic Publication: 2016 Feb 01.
Publication Year :: 2016
Abstract: Caffeine, theophylline and theobromine are the most known methylxanthines as they are present in coffee, tea and/or chocolate. In the last decades, a huge experimental effort has been devoted to get insight into the variety of actions that these compounds exert in humans. From such knowledge it is known that methylxanthines have a great potential in prevention, therapy and/or management of a variety of diseases. The benefits of methylxanthine-based therapies in the apnea of prematurity and their translational potential in pediatric affections of the respiratory tract are here presented.<br /> (Copyright © 2016 Elsevier Ltd. All rights reserved.)

Subjects :: Adolescent
Caffeine therapeutic use
Child
Child, Preschool
Humans
Infant
Infant, Newborn
Infant, Premature
Theobromine therapeutic use
Theophylline analogs & derivatives
Theophylline therapeutic use
Apnea drug therapy
Asthma drug therapy
Bronchodilator Agents therapeutic use
Cough drug therapy
Phosphodiesterase Inhibitors therapeutic use
Xanthines therapeutic use

Full Text Access

Tools